LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F Lopes-Virella Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA. Abstract Increased susceptib...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 45; no. 6; pp. 762 - 767 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
American Diabetes Association
01.06.1996
|
Online Access | Get full text |
ISSN | 0012-1797 1939-327X 0012-1797 |
DOI | 10.2337/diabetes.45.6.762 |
Cover
Loading…
Abstract | LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
A J Jenkins ,
R L Klein ,
C N Chassereau ,
K L Hermayer and
M F Lopes-Virella
Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA.
Abstract
Increased susceptibility of LDL to oxidation has been shown to be associated with the presence of coronary heart disease and
may account for the accelerated vascular disease seen in diabetes. The response of LDL to in vitro oxidative stress has been
proposed as a measure of the predisposition of LDL to the in vivo subendothelial oxidative stress. Increased susceptibility
to oxidation has been demonstrated recently in diabetic patients with poorly controlled IDDM. Thus, we conducted studies to
determine whether the increased susceptibility of LDL to oxidation was secondary to diabetes per se or to the level of glycemic
control. Fifteen IDDM patients with good glycemic control and with no evidence of macrovascular disease or proteinuria were
compared with healthy age-, sex-, race-, and BMI-matched nondiabetic subjects. Fasting blood glucose levels averaged 12.1
+/- 1.1 (mean +/- SE) vs. 4.9 +/- 0.1 mmol/l in the diabetic versus the control groups, respectively. HbA1c levels averaged
7.7 +/- 0.5 vs. 4.4 +/- 0.2%, reflecting well-controlled diabetes (P < 0.0001). Total, LDL, VLDL, and HDL cholesterol, triglyceride,
and lipoprotein(a) levels did not differ between the groups. The particle size, lipid composition, fatty acid content, antioxidant
content, and glycation were similar for LDL isolated from both groups. A rapid LDL preparation technique was used to compare
LDL susceptibility to oxidation under the following conditions: final LDL cholesterol concentration of 100 microg/ml, 5 micromol/l
of CuCl2 at 25 degrees C. There was no difference in the susceptibility to in vitro oxidation of LDL isolated from IDDM patients
compared with control subjects. There was no correlation of glycemic control with any of the parameters of the in vitro oxidation
of LDL. LDL from patients with well-controlled IDDM does not differ in composition or in susceptibility to in vitro oxidative
stress compared with LDL from nondiabetic subjects. |
---|---|
AbstractList | Abstract only LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F Lopes-Virella Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA. Abstract Increased susceptibility of LDL to oxidation has been shown to be associated with the presence of coronary heart disease and may account for the accelerated vascular disease seen in diabetes. The response of LDL to in vitro oxidative stress has been proposed as a measure of the predisposition of LDL to the in vivo subendothelial oxidative stress. Increased susceptibility to oxidation has been demonstrated recently in diabetic patients with poorly controlled IDDM. Thus, we conducted studies to determine whether the increased susceptibility of LDL to oxidation was secondary to diabetes per se or to the level of glycemic control. Fifteen IDDM patients with good glycemic control and with no evidence of macrovascular disease or proteinuria were compared with healthy age-, sex-, race-, and BMI-matched nondiabetic subjects. Fasting blood glucose levels averaged 12.1 +/- 1.1 (mean +/- SE) vs. 4.9 +/- 0.1 mmol/l in the diabetic versus the control groups, respectively. HbA1c levels averaged 7.7 +/- 0.5 vs. 4.4 +/- 0.2%, reflecting well-controlled diabetes (P < 0.0001). Total, LDL, VLDL, and HDL cholesterol, triglyceride, and lipoprotein(a) levels did not differ between the groups. The particle size, lipid composition, fatty acid content, antioxidant content, and glycation were similar for LDL isolated from both groups. A rapid LDL preparation technique was used to compare LDL susceptibility to oxidation under the following conditions: final LDL cholesterol concentration of 100 microg/ml, 5 micromol/l of CuCl2 at 25 degrees C. There was no difference in the susceptibility to in vitro oxidation of LDL isolated from IDDM patients compared with control subjects. There was no correlation of glycemic control with any of the parameters of the in vitro oxidation of LDL. LDL from patients with well-controlled IDDM does not differ in composition or in susceptibility to in vitro oxidative stress compared with LDL from nondiabetic subjects. |
Author | M F Lopes-Virella K L Hermayer A J Jenkins C N Chassereau R L Klein |
Author_xml | – sequence: 1 givenname: A. J. surname: Jenkins fullname: Jenkins, A. J. – sequence: 2 givenname: R. L. surname: Klein fullname: Klein, R. L. – sequence: 3 givenname: C. N. surname: Chassereau fullname: Chassereau, C. N. – sequence: 4 givenname: K. L. surname: Hermayer fullname: Hermayer, K. L. – sequence: 5 givenname: M. F. surname: Lopes-Virella fullname: Lopes-Virella, M. F. |
BookMark | eNp9kEtLAzEUhYNUalv9Ae6yFmbMYyaZWUrrozDiRkFXQyYPG0knJYlW_72jVQQFuYuz-b7D5UzBqPe9BuAYo5xQyk-VFZ1OOuZFmbOcM7IHJrimdUYJvx-BCUKYZJjX_ABMY3xCCLHhxmBcMVqyEk3AQ7NooAl-DTciWd2nCLc2reBWO5dJ36fgndMKLheLa2gj7H2Cax80jM9R6k2yndMweWh7-GIHGPpXq4Ym3x-CfSNc1EdfOQN3F-e386usublczs-aTBKMUqaxEIqbQglSs45qgbuSmK420iiilDCyKlVlhMaSGMo4K4jgApmKl2rAGZ0BvOuVwccYtGk3wa5FeGsxaj9War9XaouyZe2w0uDwX4606fPrFIR1_5onO3NlH1dbG_QP8xd-B_Jbgg8 |
CitedBy_id | crossref_primary_10_5352_JLS_2007_17_11_1571 crossref_primary_10_1016_S0261_5614_98_80015_0 crossref_primary_10_2337_diacare_26_3_810 crossref_primary_10_1089_15209150050502014 crossref_primary_10_1002_dmrr_231 crossref_primary_10_1016_S0953_6205_99_00009_6 crossref_primary_10_1016_j_metabol_2004_01_002 crossref_primary_10_1016_j_metabol_2006_05_012 crossref_primary_10_1111_j_1582_4934_2007_00068_x crossref_primary_10_1016_S0891_5849_97_00213_X crossref_primary_10_2337_diabetes_54_1_1 crossref_primary_10_1016_j_metabol_2004_10_012 crossref_primary_10_1111_j_1582_4934_2002_tb00456_x crossref_primary_10_1111_j_1464_5491_2006_01905_x crossref_primary_10_1002_dmrr_491 crossref_primary_10_1016_S0021_9150_00_00534_7 crossref_primary_10_1016_S0021_9150_97_00320_1 crossref_primary_10_1046_j_1464_5491_1999_00191_x crossref_primary_10_1016_S0026_0495_99_90237_8 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.2337/diabetes.45.6.762 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X 0012-1797 |
EndPage | 767 |
ExternalDocumentID | 10_2337_diabetes_45_6_762 diabetes_45_6_762 |
GroupedDBID | - 08R 0R 29F 53G 55 5GY 5RE 5RS 8F7 8GL AAQQT AAWTL AAYEP AAYJJ ABFLS ABOCM ABPTK ACGOD ACPRK ADBIT AENEX AFFNX AHMBA ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 EBS F5P FRP GICCO GJ GX1 H13 HZ IAG IAO IEA IHR INH INR IOF IPO J5H KM L7B M5 MVM O9- OB3 OBH OVD P2P RHF RHI RPM SJN SV3 TDI VH1 WH7 WOW X7M XZ YQJ ZA5 ZGI ZXP ZY1 --- .55 .GJ .XZ 08P 0R~ 1CY 354 6PF AAFWJ AAYXX ACGFO AEGXH AERZD AI. AIAGR AIZAD ALIPV CITATION EMOBN HZ~ ITC M5~ N4W OHH OK1 TEORI VVN YFH YOC ~KM |
ID | FETCH-LOGICAL-c210t-e1aad7f4da296b3ea1b52fb9fcfd2ddafc85d8fae1c2f367642a7a0f875db3e63 |
ISSN | 0012-1797 |
IngestDate | Thu Apr 24 22:54:17 EDT 2025 Tue Jul 01 03:03:52 EDT 2025 Fri Jan 15 19:48:14 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c210t-e1aad7f4da296b3ea1b52fb9fcfd2ddafc85d8fae1c2f367642a7a0f875db3e63 |
PMID | 8635650 |
PageCount | 6 |
ParticipantIDs | crossref_primary_10_2337_diabetes_45_6_762 highwire_diabetes_diabetes_45_6_762 crossref_citationtrail_10_2337_diabetes_45_6_762 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19960601 1996-06-01 |
PublicationDateYYYYMMDD | 1996-06-01 |
PublicationDate_xml | – month: 06 year: 1996 text: 19960601 day: 01 |
PublicationDecade | 1990 |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationYear | 1996 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 1.7247286 |
Snippet | LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
A J Jenkins ,
R L Klein ,
C N Chassereau ,
K L Hermayer and
M F... Abstract only |
SourceID | crossref highwire |
SourceType | Enrichment Source Index Database Publisher |
StartPage | 762 |
Title | LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation |
URI | http://diabetes.diabetesjournals.org/content/45/6/762.abstract |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqISFe0LiJbYAswRNRQuI4Sfc4LaCttDygTRpPkR3bIlKVIpoi4H_wf3dO4jihK4jxEjWufdTmfDq3nAshrwRgiKksBumnlM-NDH1QgnAbcykY16U0GBpYfEjPLvnsKrmaTH6NspY2jQzKnzvrSv6Hq7AGfMUq2Vtw1hGFBfgM_IUrcBiu_8TjeT7v6kNsd1RbqobxON_moC_BoDzP8wUOLq9XjYd5td56s26zWbBqCmzPqva-VbDZW32v1MApa7Lmo-js9tyeURxhpnEIQzfbOPBmgZPkSztO82Pgzd3q6WeBeQBabNpIbQDUhqgs6IofNtfDnVG2Ui8dEqh6YRsx7H7a6VO9Y80K4K6fpAXaWJr2glrbu2yXzGdx2zWgD1UHPAnSwJ0c99fe0nsuGxH8ICRS9CQKnhRpkaFmv8PA-8CJIPn5e6fgwefrKpvsf-leliOJNzd-xe_mTt-CemTCXOyT-9b3oCcdkB6Qia4fkrsLm13xiHwCPFHEE-3xRBFPdAtPFPFEqzUFPFHEEx3hiTYrWtW0xRN1eHpMLt-9vTg98-3oDb9kUdj4OhJCZYYrwY5TGWsRyYQZeWxKo5hSwpTTRE2N0FHJDDb940xkIjTg_SrYnsZPyF69qvVTQhNtjAHNUWYs4jqeChyUmxkDnonK0lAekLB_QkVp-9LjeJRl8Ue-HJDX7siXrinL3za_7B_78OWNXYe3IXlE7g2Af0b2mq8b_Rxs00a-aJFyDXmmkHk |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LDL+from+patients+with+well-controlled+IDDM+is+not+more+susceptible+to+in+vitro+oxidation&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Jenkins%2C+A.+J.&rft.au=Klein%2C+R.+L.&rft.au=Chassereau%2C+C.+N.&rft.au=Hermayer%2C+K.+L.&rft.date=1996-06-01&rft.issn=0012-1797&rft.eissn=0012-1797&rft.volume=45&rft.issue=6&rft.spage=762&rft.epage=767&rft_id=info:doi/10.2337%2Fdiabetes.45.6.762&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_diabetes_45_6_762 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |